Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
QuintilesIMS’ Orchestrated Customer Engagement software aims to build synergies among commercial teams.
Six years after Pfizer's landmark REMOTE trial, Parexel and Sanofi are revisiting the idea of using wearables in clinical trials.
OmniComm Systems, which owns early-phase clinical trial electronic data capture software TrialOne, has nailed a major CRO deal worth $11.7 million.
Outcome Health, a healthcare intelligence tech firm, has raised an outsize $500 million first round of funding, valuing it at $5.5 billion.
SoftBank is teaming up with Saudi Arabia’s sovereign wealth fund to invest up to $100 billion in tech companies over the next five years.
A council chaired by President Obama has called for countries to cooperate to investigate the potential uses of artificial intelligence in healthcare.
Elemental Machines is shipping its sensor-enabled smart lab system to cut the time it takes to pinpoint causes of variability and reproducibility problems.
Merck KGaA has added a fresh batch of startups to its incubator, including firms focused on automating data transfers and facilitating lab equipment sharing.
Uber and its rival Lyft were both at DPharm Disruptive Innovation US to pitch themselves as the answer to an enduring inefficiency in clinical trials.
Antidote, the tech startup formerly known as TrialReach, is gearing up to introduce a tool to automatically match patients’ EHRs to clinical trials.